Venus Remedies Ltd. Hits Lower Circuit for the 2nd Straight Session on BSE, 22 October 2026

On 22 October 2026, Venus Remedies Ltd. (VENUSREM) hit the lower circuit on BSE at Rs 1437.25, a 5% negative move from the previous close of Rs 1512.85. The company's market cap stood at Rs 2022.22 crore. The lower circuit price for the session was Rs 1437.25.

The Venus Remedies lower circuit streak has now run for 2 straight sessions. At the time of writing the stock was locked at its lower circuit level, which makes the session worth noting for short-term market participants.

Key Takeaways

• Venus Remedies Ltd. (VENUSREM) hit the lower circuit on BSE at Rs 1437.25 on 22 October 2026.
• The session move was -5% against a previous close of Rs 1512.85.
• Market capitalisation stood at Rs 2022.22 crore with a PE ratio of 17.41.
• This is the 2nd straight session at the lower circuit, with the run starting on 21 October 2026.
• A price band is an exchange trading rule, not a view on the company or a recommendation.

Key Market Data

Metric	Value
Stock	Venus Remedies Ltd.
Current Price / LTP	Rs 1437.25
Day Move	-5%
Previous Close	Rs 1512.85
Day Open	Rs 1542
Day High	Rs 1542
Day Low	Rs 1437.25
Lower Circuit Price	Rs 1437.25
Lower Circuit Limit	Rs 1437.25
Market Cap	Rs 2022.22 crore
Selected Exchange	BSE
PE Ratio	17.41

All figures above are as of 22 October 2026, sourced from Univest market data for the BSE listing. Only fields present in the source for this session are shown.

Price Action and Trading Activity

Venus Remedies Ltd. opened at Rs 1542 on BSE, compared with a previous close of Rs 1512.85. During the session, the stock traded between Rs 1437.25 and Rs 1542 before touching the lower circuit price of Rs 1437.25.

The absolute day change was Rs 75.6, while the percentage move was -5%. The event figures are kept to a single exchange so the numbers stay comparable.

The selected exchange matters because price bands, day range and previous-close values can differ across exchanges. This article uses BSE consistently for the event table and narrative. The stated lower circuit limit for the session was Rs 1437.25, which is the level the price reached.

The Venus Remedies Lower Circuit Streak So Far

This is session 2 of an unbroken run for Venus Remedies Ltd. The streak began on 21 October 2026, from a base price of Rs 1592.05. Across the run the stock has moved -9.72% in total.

A repeated lower circuit matters more than a single one. It says the order book has stayed one-sided across multiple sessions rather than reacting to a single day of news, and for anyone holding the stock it means the price on screen has been hard to trade at for several days running.

This page is the running record for the streak and is updated each session rather than being replaced by a fresh article. That keeps one address for the event instead of splitting the same story across competing pages.

Why Venus Remedies Ltd. Hit Lower Circuit

Venus Remedies Ltd. hit the lower circuit after selling pressure pushed the stock to its exchange-defined price band. No official company announcement or verified external catalyst was confirmed at the time of writing, so the move should be read primarily through price action and market sentiment.

Because no verified catalyst was available, this article does not attribute the move to earnings, corporate action, sector news, or market rumours. If a confirmed announcement becomes available later, it should be added as a separate update.

Within the session the stock reached the lower circuit level of Rs 1437.25.

What the Venus Remedies Lower Circuit Means

A lower circuit is the minimum price level a stock is allowed to reach during a trading session under the applicable exchange price band. For Venus Remedies Ltd., the captured lower circuit price was Rs 1437.25 on 22 October 2026.

The circuit mechanism is meant to slow extreme price movement and keep trading orderly. It is a market-structure fact, not a return forecast. In this article, the lower circuit explains what happened in the session and where the price band was reached.

Venus Remedies Ltd. Fundamentals and Valuation

Available market data gives a fuller picture than price action alone. For Venus Remedies Ltd., PE ratio was 17.41, PB ratio was 2.94, book value was Rs 513.74, EPS was 86.91, ROE was 16.79%, ROCE was 21.88%, dividend yield was 0.66% and debt-to-assets ratio was 0, on a market cap of Rs 2022.22 crore. These are available financial indicators and should not be read as a buy, sell, or hold view.

At the reported PB ratio of 2.94, the market valued Venus Remedies Ltd. above its reported book value per share. That premium can reflect growth expectations, asset quality, or simply thin trading in a smaller counter.

For investors tracking lower circuit moves, these metrics help separate the price event from the broader financial profile. A sharp one-day move can attract attention, but valuation and return ratios still need to be reviewed separately.

Peer and Sector Context

Venus Remedies Ltd. belongs to the Pharmaceuticals & Drugs industry within the Healthcare sector. The peer table below uses available companies from the same sector or industry to give broader valuation context.

Peer Company	Market Cap	PE	PB	ROE
Solara Active Pharma Sciences Ltd.	Rs 3127.65 crore	84.67	2.18	-0.63%
Ind-Swift Laboratories Ltd.	Rs 3024.17 crore	52.76	2.11	3.47%
Advanced Enzyme Technologies Ltd.	Rs 2908.58 crore	17.53	1.75	11.43%
Hikal Ltd.	Rs 2601.65 crore	-	2.18	-3.97%
Fredun Pharmaceuticals Ltd.	Rs 2342.81 crore	53.46	7.69	16.09%

A dash in the PE column means no PE ratio was carried for that company in the source data, which happens when reported earnings are negative or have not been refreshed. Those companies are left out of the average below rather than counted as zero.

Venus Remedies Ltd.'s PE ratio was 17.41, compared with an available peer PE average of 52.11, calculated from the 4 peer companies that had a PE on record. This comparison is a valuation reference point, not a recommendation.

Technical Snapshot

The technical snapshot adds context: RSI was 49.97, the 50-day moving average was 1631.38 and the 200-day moving average was 1460.49.

What Readers Should Know

The main confirmed fact is that Venus Remedies Ltd. hit the lower circuit on BSE at Rs 1437.25 on 22 October 2026, with a -5% day move.

The practical limitation after a lower-circuit session is execution. Sellers queue at the band with few buyers, so exiting at the quoted price may not be possible. The other limitation is that no official catalyst was confirmed at the time of writing.

Readers should treat lower circuit events as market updates, not standalone investment conclusions. The price band shows heavy near-term selling pressure, but follow-up analysis should consider business fundamentals, valuation, liquidity, risk, and confirmed company disclosures.

Frequently Asked Questions

Why did Venus Remedies Ltd. hit lower circuit on 22 October 2026?

The stock reached its lower price band after selling pressure during the session. No official company announcement or verified external catalyst was confirmed at the time of writing.

How many sessions has Venus Remedies Ltd. hit lower circuit in a row?

This is session 2 of the current run, which began on 21 October 2026. This page is updated each session rather than replaced with a new article.

What was VENUSREM share price on 22 October 2026?

The last traded price used in this article was Rs 1437.25 on BSE. That price matched the lower circuit price captured for the event.

What was the lower circuit price for VENUSREM?

The lower circuit price was Rs 1437.25. The stated exchange lower circuit limit was Rs 1437.25. The event numbers in this article are aligned to BSE.

What is Venus Remedies Ltd.'s market cap and PE ratio?

Venus Remedies Ltd.'s market cap was Rs 2022.22 crore. PE ratio was 17.41.

Which exchange and data source were used?

The selected exchange was BSE. The article uses Univest market data available at the time of generation, captured on 22 October 2026.

Does hitting a lower circuit mean Venus Remedies Ltd. is a buy or a sell?

No. A circuit is an exchange price-band rule that caps how far a stock can move in a single session. It carries no view on valuation or business quality and is not a recommendation. Any decision should rest on fundamentals, valuation, liquidity and your own risk tolerance.

Can you buy or sell Venus Remedies Ltd. shares when the stock is at the lower circuit?

It is usually difficult. At the lower circuit, sell orders queue up with few buyers, so exiting at the quoted price may not be possible. Orders can stay unfilled until buying interest returns.

What happens the next trading session after a lower circuit?

There is no fixed outcome. The band resets each session, so the stock can open freely, hit the same band again, or reverse. The exchange can also revise the applicable band width. The useful signals to watch are whether the company files any disclosure explaining the move.

What is the lower circuit limit set at for Indian stocks?

Exchange price bands are commonly set at 2%, 5%, 10% or 20% depending on the security, and the applicable band can be revised by the exchange. For Venus Remedies Ltd. the stated limit was Rs 1437.25. For this session, Venus Remedies Ltd. moved -5%.